India vs United States: Measles-containing-vaccine second-dose (MCV2) immunization coverage
India
95.0%
in 2025
United States
95.0%
in 2025
India rank
29th
United States rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- India
- United States
How they compare
India currently reports 95.0% against 95.0% in United States, a difference of 0.0%.
Across all 26 years both countries report, United States has been ahead every year.
India ranks 29th and United States ranks 29th of 194 countries.
United States has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | India | United States | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 86.2% | 86.2% | United States |
| 2010s | 56.5% | 92.3% | 35.8% | United States |
| 2020s | 88.3% | 95.0% | 6.7% | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, India or United States?
- India, at 95.0% against 95.0% in United States as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between India and United States?
- 0.0%, with India ahead.
- How many years of comparable data are there for India and United States?
- 26 years are reported by both, from 2000 to 2025.
- How do India and United States rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- India ranks 29th and United States ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.